IPSC vs MAS · rev $6.6M vs P/E 18, rev $7.83B
Century Therapeutics Inc (IPSC) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
IPSC currently screens at market cap $47.8M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the IPSC and MAS stock pages for the full models.
Not investment advice.